Sequential Windowed Acquisition Mass Spectrometry for Host Cell Protein Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting host cell protein contaminants in protein biotherapeutics, such as non-data-independent acquisition mass spectrometry and enzyme-linked immunosorbent assay (ELISA), rely on assumptions about immune responses between rabbits and humans, leading to potential undetected contaminants causing problematic reactions in human patients.
Innovation Solution
The use of sequential windowed acquisition tandem mass spectrometry, which performs data-independent analysis without prior knowledge of contaminating proteins, producing a comprehensive record of product ion spectra for matching against a library of host cell proteins to detect contaminants.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If ELISA or non-data-independent mass spectrometry methods are used to detect host cell protein contaminants, then the detection process is simpler and faster, but the reliability of detection is reduced due to false negatives from species-specific immune response differences
Solution Approach 1:
The patent replaces the biological immune response mechanism (rabbit antibodies detecting host cell proteins) with a physical mass spectrometry mechanism. The sequential windowed acquisition method uses mass-to-charge ratio detection and fragmentation pattern analysis, eliminating species-specific immune response limitations while maintaining high detection reliability through comprehensive spectral matching against host cell protein libraries.
Solution Approach 2:
The patent performs preliminary action by pre-acquiring comprehensive product ion spectra from host cell proteins and building a reference library before actual contaminant detection. This spectral library contains fragmentation patterns of all possible host cell protein contaminants, enabling retrospective identification without requiring prior knowledge of which specific contaminants may be present in a given sample.
2Measurement precision
If sequential windowed acquisition tandem mass spectrometry is used to detect host cell contaminants, then the detection sensitivity and reliability are improved, but the analysis time and computational complexity increase
Solution Approach 1:
The patent implements periodic action through sequential windowed acquisition, where the mass spectrometer systematically steps through predefined precursor mass windows in a periodic sequence. Each window is acquired, fragmented, and analyzed in repeating cycles, ensuring comprehensive coverage of the mass range while maintaining efficient throughput through standardized periodic operation.
Solution Approach 2:
The patent uses copying by comparing measured product ion spectra against pre-stored reference spectra from the host cell protein spectral library. Instead of attempting to identify unknown contaminants through complex real-time analysis, the system copies known spectral patterns from the library and matches them against experimental data, dramatically reducing computational complexity while maintaining high detection sensitivity.
3Adaptability or versatility
If data-independent acquisition is performed without prior information about contaminants, then the versatility and comprehensiveness of detection are improved, but the device complexity and data processing requirements increase
Solution Approach 1:
The patent achieves universality through the host cell protein spectral library, which contains fragmentation patterns for all possible host cell protein contaminants that could be present in any biotherapeutic product. This single comprehensive library enables the detection of any host cell protein contaminant across different product types, cell lines, and manufacturing processes, providing universal adaptability without requiring method redevelopment.
Solution Approach 2:
The patent extracts only the essential identification information (product ion spectra and fragmentation patterns) from the complex mass spectrometry data, separating the critical contaminant detection signals from the overwhelming background data. By extracting and storing only these key spectral features in the reference library, the system reduces data processing complexity while maintaining comprehensive detection capability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides higher sensitivity and confidence in detecting host cell contaminants, reducing reliance on temperamental antibody reagents and enabling comprehensive quantitation and tracking of product changes, ensuring the safety and quality of biotherapeutics.
Implementation Method 1
a tandem mass spectrometer performs sequential windowed acquisition on a protein biotherapeutic product sample by sequentially stepping a precursor mass window across a mass range, fragmenting transmitted precursor ions of each stepped precursor mass window, and analyzing product ions produced from the fragmented transmitted precursor ions
Data Source
Figure 1
Figure 2
Figure 3
AI summary
Systems and methods are provided for detecting host cell contaminants in a protein biotherapeutic product using sequential windowed acquisition tandem mass spectrometry. Sequential windowed acquisition is performed on a protein biotherapeutic product sample by sequentially stepping a precursor mass window across a mass range, fragmenting transmitted precursor ions of each stepped precursor mass window, and analyzing product ions produced from the fragmented transmitted precursor ions. The sequential windowed acquisition is performed without any information about contaminating proteins before data acquisition, and produces data for every product ion of every transmitted precursor ion for the mass range. One or more measured product ion spectra are received, and compared to a library of host cell proteins. One or more host cell contaminants are detected by reporting host cell proteins from the library that match the one or more measured product ion spectra.